Skip to main content
. Author manuscript; available in PMC: 2015 Jun 29.
Published in final edited form as: Lipids. 2011 Jun 2;46(10):907–921. doi: 10.1007/s11745-011-3572-y

Fig. 6.

Fig. 6

Effects of 3dSB on IBP inhibitor-induced changes in FPP and GGPP levels in U266 cells. Cells were incubated in the presence or absence of 1 μM 3dSB and/or 10 μM lovastatin, 50 μM ZA, or 10 μM DGBP for 24 h in media containing either standard FCS or LPDS. Intracellular FPP and GGPP levels were determined as described in the section “Materials and methods” and are expressed as a percentage of the control (mean ± SD of three independent experiments). The * denotes p < 0.05 per unpaired two-tailed t test and compares the IBP inhibitor + 3dSB combination to the IBP inhibitor alone